Rat RT6 proteins, and perhaps mouse Rt6, identify a set of immunoregulatory T lymphocytes. Rat RT6.1 (RT6.1) and rat RT6.2 (RT6.2) are NAD glycohydrolases, which catalyze auto-ADP-ribosylation, but not ADP-ribosylation of exogenous proteins. Mouse Rt6.1 (mRt6.1) also catalyzes auto-ADP-ribosylation. The activity of mouse cytotoxic T lymphocytes is reportedly inhibited by ADP-ribosylation of surface proteins, raising the possibility that mRt6 may participate in this process. The reactions catalyzed by mRt6, would, however, need to be more diverse than those of the rat homologues and include the ADP-ribosylation of acceptors other than itself. To test this hypothesis, mRt6.1 and rat RT6. 
Rat RT6 proteins appear to identify a regulatory T cell population capable of modulating autoimmunity (1) . Diabetesprone BB rats are severely deficient in RT6 ϩ T cells and spontaneously develop insulin-dependent diabetes mellitus (2, 3) . Transfusion of spleen cells from histocompatible rats prevents diabetes provided that RT6 ϩ T cells become engrafted (4, 5) . Conversely, diabetes-resistant BB rats have normal numbers of RT6 ϩ T cells and fail to manifest autoimmunity (1, 2) . Depletion of RT6 ϩ T cells induces insulitis, diabetes, and thyroiditis in these animals (6 -8) . RT6 ϩ T cells have been suggested to be important also in the modulation of autoimmunity in the irradiated, thymectomized PVG model of insulin-dependent diabetes mellitus (9) , and in the BN rat model of mercury chloride-induced autoimmune glomerulonephritis (10) . The mechanism(s) by which RT6 ϩ T cells regulate autoimmunity is uncertain, but may involve the RT6 protein itself.
The rat RT6 proteins are linked to the surface of T cells via a glycosylphosphatidylinositol (GPI) 1 -linkage (11, 12) . Deduced amino acid sequences obtained from cDNA for two rat allotypes, RT6.1 and RT6.2, with molecular masses of 25-35 kDa and 24 -26 kDa, respectively, contain hydrophobic amino-and carboxyl-terminal sequences, consistent with those in GPIlinked proteins (13, 14) . The internal, coding region is remarkable for consensus sequences similar to those found in bacterial toxin ADP-ribosyltransferases and believed to be involved in catalytic activity (15) . Consistent with this observation, the RT6 protein exhibited NAD glycohydrolase (15) and auto-ADPribosyltransferase activities (16, 17) . These enzymatic activities of RT6 have recently been postulated to be important in the inhibition of T cell proliferation following incubation of cells in the presence of NAD (16) .
Two mouse Rt6 genes have recently been identified and are transcribed (18 -20) . Expression of mouse Rt6 protein by immunoblotting and RT6 gene expression appear to be restricted to T cells (18, 21) . Reduced levels of Rt6 gene expression have been reported in two models of autoimmunity in mice (18, 19) . In the spontaneously diabetic nonobese diabetic mouse, levels of Rt6-specific mRNA in the spleens of 8-week-old mice were lower than those of control nonobese nondiabetic mice (18) . In the NZW and (NZB ϩ NZW)F 1 mouse, which are models of systemic lupus erythematosus, defects in the structure and expression of the Rt6 gene were also observed (19) . Similar to the rat homologue, mouse Rt6.1 had auto-ADP-ribosylation activity (16, 21) . The immunomodulatory function of mRt6 ϩ T-lymphocytes, or the role of mRt6 enzymatic activities in immune modulation, have not been determined. Recently, it was suggested that cytotoxic T cell (CTL) activity in mice may be regulated by GPI-linked ADP-ribosyltransferases that have many of the characteristics of the rat RT6 proteins (22, 23) and catalyze the modification of surface proteins (24) .
Although various members of the rat RT6 and mouse Rt6 family of proteins possess NAD glycohydrolase and auto-ADPribosyltransferase activity, it was not evident that they could catalyze intermolecular reactions as described for CTL cells. In fact, the rat RT6.2 protein, which was shown to be an NAD glycohydrolase (15) and auto-ADP-ribosyltransferase, specifically did not catalyze the ADP-ribosylation of protein and simple guanidino compounds such as arginine and agmatine (16, 17) . The present study was undertaken to determine whether * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.the mRt6.1 protein, in contrast to the rat RT6 protein, could catalyze intermolecular reactions such as the ADP-ribosylation of free proteins and agmatine. These enzymatic activities would be consistent with a possible immunomodulatory function in mouse CTL and provide a potential mechanism by which mRt6 ϩ T cells, and/or protein could influence autoimmunity. 
EXPERIMENTAL PROCEDURES

Materials
Methods
Subcloning of mRt6.1 cDNA and Transfection of NMU Cells-mRt6.1 cDNA was subcloned into a pMAMneo expression vector as described previously (25) . The mRt6.1 insert was sequenced to confirm its identity with that in GenBank TM (accession no. X52991). The mRt6.1 cDNA was amplified from purified plasmid cDNA (mRt6.1 cDNA in pAcSG2 vector) by PCR, using forward (5Ј-ACG ACG GCT AGC ATG CCA TCA AAT AAT TTC AAG-3Ј) and reverse (5Ј-CGT CGT CTC GAG CTA CGG CTC AGC AAG AGT AAG-3Ј) primers (100 pmol each) under the following conditions: 60 s at 95°C, followed by 25 cycles at 95°C for 60 s; 55°C, 60 s; 72°C, 90 s; and ending at 72°C for 7 min. The PCR product was isolated on a 3% NuSieve GTG-agarose gel followed by QIAEX purification of the gel band. The purified PCR fragment was digested with XhoI and NheI and ligated into the NheI (5Ј) and XhoI (3Ј) sites of the pMAMneo vector. DH5␣ competent cells were transformed with the ligated product and grown on LB plates containing ampicillin (50 g/ ml). The subcloned mRt6.1 cDNA in pMAMneo was amplified, and then purified using the QIAGEN plasmid purification kit. The subclone was sequenced using the 7-deaza-dGTP sequencing kit to verify orientation. NMU cells were transfected with 30 g of the mRt6.1 subclone by the calcium phosphate/HEPES-buffered saline precipitation method.
Transformed NMU cells were selected with G418 (500 g/ml) and maintained in Eagle's minimal essential medium containing 10% fetal bovine serum with G418 (500 g/ml).
Induction of mRt6.1 in Transformed NMU Cells with Dexamethasone-Expression of ADP-ribosyltransferase was induced by incubating 2.5 ϫ 10 6 transformed NMU cells with 1 M dexamethasone sodium phosphate for the indicated times (6, 24, 48 , and 72 h). Cells were washed with DPBS and incubated with or without 2 units of PI-PLC in 1.5 ml of DPBS at 37°C. The media were collected. Cells were trypsinized, washed twice in DPBS, and lysed in 0.7 ml of hypotonic lysis buffer (10 mM potassium phosphate, pH 7.5, 1 mM EDTA) with three freeze/thaw cycles (dry ice/room temperature). Lysed cells were centrifuged for 1 h at 100,000 ϫ g at 4°C. The supernatant (0.7 ml) was collected; the membrane fraction was suspended in 0.7 ml of lysis buffer and sonified. ADP-ribosyltransferase activity was determined in samples (75 l) of the medium, cell supernatant, and cell membranes. Data are expressed as total activity per fraction (picomoles of [
C]ADPribosylagmatine formed in 26 h in the transferase assay).
Assay of ADP-ribosyltransferase Activity from NMU Cells-The ADPribosyltransferase reaction was carried out for 26 h in 0.3 ml of reaction mix containing 50 mM potassium phosphate, pH 7.5, 0.1 mM nicotinamide [adenine-U-14 C]NAD (0.05 Ci), with or without 20 mM agmatine. Duplicate samples were incubated at 30°C, and at the end of the incubation, two 100-l samples from each assay were applied to columns (1 ml bed volume) of Dowex AG1-X2 resin (26) . [
14 C]ADP-ribosylagmatine was eluted with 5 ml of H 2 O for radioassay.
Protein Assay-Protein was determined using BCA protein assay reagent (Pierce) with bovine serum albumin as a standard.
Preparation of Rat Brain ADP-ribosylarginine Hydrolase and Turkey Erythrocyte ADP-ribosyltransferase-ADP-ribosylarginine hydrolase, purified from rat brain as described earlier, contained one major 39-kDa protein band on SDS-polyacrylamide gel electrophoresis (27) . Turkey erythrocyte ADP-ribosyltransferase was purified as described previously (28) .
Preparation of mRt6.1 and Rat RT6.2 in Sf9 Cells-Recombinant mRt6.1 and RT6.2 were synthesized in Sf9 cells under the control of a baculovirus promoter, as described previously (16) . Two rat RT6. (Table I) . These data are compatible with the conclusion that, in the presence of an ADP-ribose acceptor, the enzyme is primarily a transferase, with only minimal, uncoupled NAD glycohydrolase activity. In the absence of agmatine (Table I) . Again, these data support the hypothesis that the enzyme is not as efficient as an NAD glycohydrolase as it is an ADP-ribosyltransferase. In contrast, the rat RT6.2, synthesized in the Sf9 system, did not appear to catalyze the formation of [adenine-U-14 C]ADP-ribosylagmatine from [adenine-U- (Table I) . For NAD, the K m of RT6.2-LR was 23.4 M Ϯ 3.2; the K m of RT6.2-GB was 41.0 M Ϯ 9.4; both were significantly lower than that of mRt6.1 (1.9 mM Ϯ 0.3) ( Table II) . The K m for NAD of mRt6.1 was similar to that of cholera toxin (29), a bacterial NAD: arginine ADP-ribosyltransferase. The mRt6.1 K m for agmatine of 4.8 mM Ϯ 0.3 was significantly lower than that reported for the toxin (30) .
To verify that mRt6.1 was indeed catalyzing the formation of an ADP-ribose-linkage to simple guanidino compounds and that the ADP-ribose-guanidino linkage was identical to that formed by erythrocyte and cardiac muscle NAD:arginine ADPribosyltransferases (25, 31) , [ 14 C]arginine and saturating concentrations of unlabeled NAD were incubated with or without mRt6.1, and the products resolved by SAX-HPLC (Fig. 1) . [ 14 C]Arginine eluted at 2-4 min; with mRt6.1, a new radiolabeled peak, corresponding to 6.4% of the total radiolabel, was observed at 7-9 min (Fig. 1) . To determine whether this peak represented ADP-ribosyl-[
14 C]arginine, it was concentrated and incubated with or without Mg 2ϩ and DTT in the presence of an ADP-ribosylarginine hydrolase, which cleaves the ADPribose-arginine linkage (27, 32) . ADP-ribosylarginine hydrolase is dependent on Mg 2ϩ and DTT for activity, and degrades stereospecifically the ␣-anomeric product of the erythrocyte NEN, 2 Ci/assay) with or without type VII-S histone (Sigma), 10 g, and/or 0.1 mM ADP-ribose (ADPR) (Sigma), in a total volume of 100 l. Reactions were stopped by addition of 500 l of cold 20% TCA, stored overnight, and centrifuged (18, 320 ϫ g, 15 min) . Precipitated proteins were solubilized in Laemmli sample buffer and separated by SDS-polyacrylamide gel electrophoresis in 12% gels, which were stained with Coomassie Blue, destained, dried, and exposed to Kodak XAR film for 2 h. Similar results were obtained with the rat RT6.2-GB.
transferase-catalyzed reaction (27, 33) . The reaction products were again subjected to SAX-HPLC. In the presence of Mg 2ϩ , DTT, and hydrolase a new peak, eluting at 2-4 min, corresponding to [ 14 C]arginine and representing 72% of the total radiolabel, was formed (Fig. 2) . mRt6.1 utilized histones as ADP-ribose acceptors and, in the presence of [ (Fig. 3) . Free ADP-ribose did not inhibit [ 32 P]ADP-ribosylation of histone, suggesting that a nonenzymatic pathway resulting from the initial generation of ADPribose by an NAD glycohydrolase, followed by the nonenzymatic addition of ADP-ribose to protein, was not responsible for the result. In addition, rat RT6.2 is more active as an NAD glycohydrolase than is the mRt6.1 and it did not, under these conditions, cause ADP-ribosylation of histone (Fig. 3) . It is noted also that auto-ADP-ribosylation of rat RT6.2 was not inhibited by ADP-ribose and is, in all likelihood, enzymatic. For the avian erythrocyte transferase A, histones serve as both ADP-ribose acceptors and activators of the enzyme (26, 34) . To determine whether histones enhanced mRt6.1 activity, the enzyme was incubated with [adenine-U-14 C]NAD and agmatine, and radiolabeled ADP-ribosylagmatine was isolated (Table III) . Histones inhibited ADP-ribosylagmatine formation, presumably, in part, by serving as an alternative ADP-ribose acceptor and competing for the catalytic site, but no enhancement of mRT6.1 activity was observed.
Expression of mRt6.1 protein in lymphocytes has been demonstrated (21) . It appeared, therefore, that the signal sequence at the carboxyl terminus was recognized by the enzymes involved in the formation of a GPI-linked protein (35) . mRt6.1 was expressed under the control of a dexamethasone-regulated promoter in rat NMU cells. Under the assay conditions, NMU cells transfected with vector alone did not exhibit ADP-ribosyltransferase activity (data not shown). The cells, however, possessed significant activities that metabolized NAD, and caused release of nicotinamide (data not shown). For that reason, ADP-ribosyltransferase activity was measured directly with [adenine-U-14 C]NAD and agmatine as substrates, and the formation of [adenine-U-14 C]ADP-ribosylagmatine was monitored. As shown in Table IV , following induction with dexamethasone, NMU cells transfected with the mRt6.1 gene exhibited a time-dependent increase in ADP-ribosyltransferase activity. At 6 h following induction, activity was primarily associated with the cell pellet and was not released with PI-PLC. At 24 h, transferase activity was increased further and was released by PI-PLC. Although the total transferase activity declined after 48-and 72-h incubations with dexamethasone, the fraction susceptible to release by incubation with PI-PLC remained constant. These studies suggest that, following induction by dexamethasone, there is a delay in processing the mRt6.1 transferase to a PI-PLC-releasable form by NMU cells, although the carboxyl-terminal signal sequence in mRt6.1 is sufficient for the addition of the GPI anchor.
The mouse Rt6 and rat RT6 families of proteins share both structural and functional properties (13-17, 21, 36) . The deduced amino acid sequences of all four proteins contain signal sequences at their amino and carboxyl termini believed to be involved, respectively, in export to the endoplasmic reticulum and attachment of a GPI anchor (13, 14, 36) . The internal regions of the coding domain contain the consensus sequences found in ADP-ribosyltransferases and NAD glycohydrolases, which are believed to be involved in the formation of the catalytic site (37, 38) . Although the RT6 proteins, other mammalian and avian ADP-ribosyltransferases, and bacterial toxin ADPribosyltransferases contain the consensus sequences, their enzymatic activities appear clearly to differ (25, 31, (37) (38) (39) (40) (41) . The rat RT6.1 and RT6.2 appear to be NAD glycohydrolases (15, 17) ; RT6.2 catalyzes auto-ADP-ribosylation, but there is some disagreement as to whether RT6.1 possesses this activity (17, 42) . Unlike the avian erythrocyte and rabbit muscle ADP- 14 C]NAD (ϳ107,000 cpm) with or without 20 mM agmatine or 50 g of histone in a total volume of 300 l. 100-l samples were applied to columns (0.5 ϫ 4 cm) of AG1-X2 resin, which were eluted with water. Apparent ADP-ribosylagmatine formation in columns 3 and 4 reflects modified histone and/or background. 6 ) transformed with mRt6.1 as described under "Methods" were incubated in DPBS with or without 2 units of PI-PLC for 1 h at 37°C. DPBS fractions were collected, cells lysed, and the lysates centrifuged at 100,000 ϫ g ϫ 1 h. ADP-ribosyltransferase activity was determined in samples (75 l) of the DPBS (1.5 ml, total volume), cell supernatant (0.7 ml, total volume) and membranes (cell pellet; 0.7 ml, total volume). Mouse Rt6.1 NAD:Arginine ADP-ribosyltransferaseribosyltransferases (28, 31, 43) , rat RT6.2 did not appear to use agmatine or similar, simple guanidino compounds as acceptors (15) . A recent report on mouse Rt6.2 demonstrated that it had NAD glycohydrolase activity that was inhibited by agmatine; it was not established whether agmatine was used as an ADPribose acceptor (21) . mRt6.1 protein was observed to have auto-ADP-ribosyltransferase activity (21) ; based on chemical stability of the ADP-ribose-protein bond, it was concluded that arginine was the ADP-ribose acceptor (21) . It is not clear whether the auto-ADP-ribosylation reaction represents a single or multiple turnover reaction. Rat RT6.2, on the other hand, is an auto-ADP-ribosyltransferase but does not catalyze the ADP-ribosylation of arginine (15) . The current report clearly demonstrates that mRt6.1 differs significantly in enzymatic properties from rat RT6.1 (17) and RT6.2 (15) . Unlike the rat proteins, mRt6.1 catalyzes the stereospecific formation of ADPribosylagmatine, similar to cholera toxin and eukaryotic NAD: arginine ADP-ribosyltransferases (38, 44, 45) . In the presence of agmatine, nicotinamide release parallels ADP-ribosylagmatine formation. As shown by the NMU cell transfection experiments, the putative carboxyl-terminal signal sequence for mRt6 is processed appropriately in mammalian cells leading to the addition of a GPI anchor. Thus, the mRt6.1 could serve a regulatory role in the ADP-ribosylation of cell surface proteins, suggesting a possible mechanism by which mRt6 protein on the surface of Rt6 ϩ cells might regulate immune function.
